Please try another search
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that completed phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that completed phase 2b clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company has a license and collaboration agreement with Takeda to commercialize rusfertide; and JNJ Innovative Medicines to co-develop Interleukin-23 receptor antagonist compound JNJ-2113. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Name | Age | Since | Title |
---|---|---|---|
Ellen J. Scherl | - | - | Clinical Advisor |
Harold E. Selick | 67 | 2009 | Independent Chairman |
Wayne I. Lencer | - | - | Clinical Advisor |
Lewis T. Williams | 72 | 2017 | Independent Director |
Mark A. Gallop | 58 | - | Scientific Advisor |
Harlan F. Weisman | 69 | 2015 | Clinical Advisor |
Charles S. Craik | - | - | Scientific Advisor |
Chaitan S. Khosla | 56 | 2014 | Chairman of Scientific Advisory Board |
Aida Habtezion | - | - | Clinical Advisor |
William D. Waddill | 64 | 2016 | Independent Director |
Bryan Giraudo | 45 | 2018 | Independent Director |
Dinesh V. Patel | 65 | 2008 | CEO, President, Secretary & Director |
K. C. Nicolaou | - | - | Member of Scientific Advisory Board |
Jason G. Cyster | - | - | Member of Scientific Advisory Board |
Sarah A. O’Dowd | 73 | 2020 | Independent Director |
Daniel N. Swisher | 60 | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review